Anavex Life Sciences (AVXL) Tops Q3 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q3 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
• CoStar Group acquires Zonda for $800M, adding new home data